FY27 radiopharmaceuticals

Active Purchase Order Awarded

Contract number
W81K0026PA195
Awardee
Awarding agency
Obligated
$0

Award facts

Contract value 0% obligated
$1,036,491.00 Current and potential, with all options
Completion date 22% complete
Current and potential, with all options
Contracting staff
Funding agency
Defense Health Agency Department of Defense
NAICS code
325412 Pharmaceutical Preparation Manufacturing
PSC
6505 Drugs And Biologicals
Set-aside
No set-aside
Competition
Not Competed under SAP · 1 offer Simplified Acquisition
Pricing
Firm Fixed Price
Place of performance
JBSA FT SAM HOUSTON, TX 78234, USA

Award details come from SAM.gov/FPDS.

About this award

The Defense Health Agency awarded a purchase order to Sofie CO., doing business as IBA Molecular, on October 1, 2026, for FY27 radiopharmaceuticals with a firm fixed price and a ceiling value of $1,036,491. The order was procured with no set-aside. Place of performance is JBSA Fort Sam Houston, Texas 78234, and the ultimate completion date is September 30, 2027.

Quick answers

Who was awarded contract W81K0026PA195?

W81K0026PA195 was awarded to Sofie CO. by Medical Command (Department of the Army) on August 6, 2026.

How much is contract W81K0026PA195 worth?

The government has obligated $0 on W81K0026PA195. Its current value, with exercised options, is $1,036,491.

Which agency awarded contract W81K0026PA195?

Medical Command (Department of the Army) awarded W81K0026PA195, with funding from Defense Health Agency (Department of Defense).

Was contract W81K0026PA195 competed?

The extent of competition for W81K0026PA195 was not competed under sap. The government received 1 offer.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award